Blood News and Research

RSS

New study identifies crizotinib drug as possible new coating for drug-eluting stents

A new study has identified an FDA approved cancer drug, crizotinib, as a possible new coating for drug-eluting stents. Researchers found that crizotinib in mice helped prevent the narrowing of blood vessels after stenting without affecting the blood vessel lining.

19 Nov 2014

Cardiac stem cell treatment restores heart function damaged by Duchenne muscular dystrophy

Researchers at the Cedars-Sinai Heart Institute have found that injections of cardiac stem cells might help reverse heart damage caused by Duchenne muscular dystrophy, potentially resulting in a longer life expectancy for patients with the chronic muscle-wasting disease.

18 Nov 2014

Lifestyle of young people could pose risk for developing diabetes mellitus

Research performed by the University of Veracruz, in the east coast of Mexico, called Lifestyles Nutrition Students and Risk of Type II Diabetes, showed that the lifestyle of young people between 17 and 24 years of age, like lack of physical activity, mild psychological stress, and the omission of breakfast could pose a risk for developing diseases such as diabetes mellitus.

18 Nov 2014

Moffitt announces development of innovative investigational biologic agent for MDS

In a major step to treat patients living with Myelodysplastic Syndromes (MDS), a group of diseases that affect the bone marrow and blood, Moffitt Cancer Center today announced the development of an innovative investigational biologic agent that could improve patient response and outcomes for MDS and other diseases.

18 Nov 2014

Nationwide STEMI rates drop, reveals Vanderbilt study

The most emergent form of heart attacks is decreasing nationwide, but this declining incidence could affect emergency departments' quality and timeliness of care.

18 Nov 2014

Strategy to stem infections in livestock, endangered species

When a viral infection spread through five genetically identical mice in a row, the virus replicated faster and became more virulent or severe. But when the infection spread one-by-one through five genetically diverse mice, the virus had trouble adapting and became less virulent.

18 Nov 2014

3SBio enters into exclusive license agreement with PharmAbcine for Tanibirumab

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced it has entered into an exclusive license with PharmAbcine, Inc. for the development, manufacturing and marketing of Tanibirumab, an anti-VEGFR2/KDR antibody for cancer in the territory of Greater China (including Mainland China, Taiwan, Hong Kong and Macau) and several emerging countries, including Thailand, Brazil and Russia.

18 Nov 2014

Statin use linked to improved RCC surgery outcomes

Statin use at the time of surgery is associated with improved overall survival and disease-specific survival in patients with renal cell carcinoma of any stage, US researchers report.

18 Nov 2014

Nonlinear correlation between axitinib dose, dBP increase

A pharmacokinetic–pharmacodynamic model shows that diastolic blood pressure rises with increasing doses of axitinib in patients with metastatic renal cell carcinoma, US researchers report, although this relationship is not linear.

18 Nov 2014

Investigational treatment shows promise against Marfan syndrome

An investigational treatment for Marfan syndrome is as effective as the standard therapy at slowing enlargement of the aorta, the large artery of the heart that delivers blood to the body, new research shows. The findings indicate a second treatment option for Marfan patients, who are at high risk of sudden death from tears in the aorta.

18 Nov 2014

Early sodium supplementation improves weight gain in premature infants

Early sodium supplementation for very premature infants can enhance weight gain according to a recent study by researchers at the University of Cincinnati Medical Center and Cincinnati Children's Hospital Medical Center.

18 Nov 2014

Health Canada to review evidence on the safety of long-term use of prescription blood-thinners

Health Canada is aware of and will be reviewing new evidence on the safety of long-term use of the prescription blood-thinners clopidogrel (Plavix) and prasugrel (Effient).

18 Nov 2014

Cigna Foundation awards World of Difference grant to improve heart healthy behaviors in women

When it comes to hearts, men and women are not created equally. Women who have experienced a heart attack have a higher risk of a subsequent heart attack, or death, compared to men, according to the American Heart Association.

18 Nov 2014

Research finding could have major implications for diabetes treatment

Harvard Stem Cell Institute researchers, representing five Harvard departments and affiliated institutions as well as the Massachusetts Institute of Technology, have demonstrated that adult cells, reprogrammed into another cell type in a living animal, can remain functional over a long period.

18 Nov 2014

Edison announces initiation of full coverage on ADRs of DBV Technologies

Edison Investment Research, a leading international investment research firm, announces the initiation of full coverage on the US-listed ADRs of DBV Technologies, the French allergy company focused on peanut allergy.

18 Nov 2014

BMI plays role in rheumatoid arthritis patients' ability to achieve sustained remission

A study by Hospital for Special Surgery researchers finds that body mass index (BMI) plays a role in rheumatoid arthritis (RA) patients' ability to achieve a sustained remission. Looking at patients who had received an RA diagnosis within the past 12 months, investigators found that those who were significantly underweight or overweight/obese were the least likely to remain in remission.

18 Nov 2014

Researchers discover second protein associated with membranous nephropathy

An international team of researchers from France, Germany, and the US have identified a protein that turns a person's immune system against itself in a form of kidney disease called membranous nephropathy (MN). The new research was presented at ASN Kidney Week 2014 in Philadelphia and published online in the New England Journal of Medicine.

18 Nov 2014

Researchers present results of The Heart of New Ulm Project at AHA Scientific Sessions

Researchers from Allina Health and the Minneapolis Heart Institute Foundation have presented on the results and implications of The Heart of New Ulm Project on heart disease risk factors at the American Heart Association Scientific Sessions in Chicago, Ill.

18 Nov 2014

VEGF-B can regenerate damaged peripheral nerves without causing growth of new blood vessels

Researchers at the University of Illinois at Chicago College of Medicine have found that a growth factor can regenerate damaged peripheral nerves without causing the growth of new blood vessels -- making it a unique candidate to treat nerve damage in areas of the body where the proliferation of blood vessels would be a drawback.

18 Nov 2014

Asthma associated with higher risk of heart attack or stroke

Asthma that requires daily medication is associated with a significantly higher risk of heart attack or stroke, according to a new study from the University of Wisconsin School of Medicine and Public Health.

18 Nov 2014

Blood News and Research

New study identifies crizotinib drug as possible new coating for drug-eluting stents

Cardiac stem cell treatment restores heart function damaged by Duchenne muscular dystrophy

Lifestyle of young people could pose risk for developing diabetes mellitus

Moffitt announces development of innovative investigational biologic agent for MDS

Nationwide STEMI rates drop, reveals Vanderbilt study

Strategy to stem infections in livestock, endangered species

3SBio enters into exclusive license agreement with PharmAbcine for Tanibirumab

Statin use linked to improved RCC surgery outcomes

Nonlinear correlation between axitinib dose, dBP increase

Investigational treatment shows promise against Marfan syndrome

Early sodium supplementation improves weight gain in premature infants

Health Canada to review evidence on the safety of long-term use of prescription blood-thinners

Cigna Foundation awards World of Difference grant to improve heart healthy behaviors in women

Research finding could have major implications for diabetes treatment

Edison announces initiation of full coverage on ADRs of DBV Technologies

BMI plays role in rheumatoid arthritis patients' ability to achieve sustained remission

Researchers discover second protein associated with membranous nephropathy

Researchers present results of The Heart of New Ulm Project at AHA Scientific Sessions

VEGF-B can regenerate damaged peripheral nerves without causing growth of new blood vessels

Asthma associated with higher risk of heart attack or stroke

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News